Details for New Drug Application (NDA): 209041
✉ Email this page to a colleague
The generic ingredient in BUDESONIDE is budesonide. There are twenty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the budesonide profile page.
Summary for 209041
Tradename: | BUDESONIDE |
Applicant: | Sciecure Pharma Inc |
Ingredient: | budesonide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 209041
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED RELEASE;ORAL | Strength | 3MG | ||||
Approval Date: | Sep 28, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription